Panbela Therapeutics, Inc. Notes Assumed
Panbela Therapeutics, Inc. reported Notes Assumed of $250.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2017-03-30
- Panbela Therapeutics, Inc. notes assumed for the quarter ending 2015-12-31 was $0.00.
- Panbela Therapeutics, Inc. notes assumed for fiscal 2015 was $250.00K.
| Period end | Notes Assumed | Notes Assumed 3 month | Notes Assumed 9 month | Notes Assumed 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $250.00K 10-K · filed 2017-03-30 | ||
| 2015-09-30 | $250.00K 10-Q · filed 2016-11-10 | |||
| 2015-09-28 | $250.00K 10-K · filed 2017-03-30 |